Our group has previously shown that BIN1, originally identified as a MYC-interacting tumor suppressor [21], functions as a cellular inhibitor of PARP1 in vitro and that MYC induces cisplatin resistance by liberating intrinsic PARP1 activity through directly suppressing BIN1 levels [33]. Here, PARP1 is linked to neoplasm.